Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients
- نوع فایل : کتاب
- زبان : انگلیسی
- مؤلف : Michael Fiegl & Florian Falkner & Michael Steurer & Niklas Zojer & Georg Hopfinger & Ferdinand Haslbauer & Guntram Winder & Daniela Voskova & Johan
- چاپ و سال / کشور: 2011
Description
infections (50%), febrile reactions upon alemtuzumab administration (38%), exanthema (21%), and grade 4 neutropenia (13%) and thrombocytopenia (17%). We conclude that alemtuzumab retreatment represents an effective and tolerable therapeutic option for selected patients with CLL.
Ann Hematol (2011) 90:1083–1091 DOI 10.1007/s00277-011-1192-5 Received: 24 July 2010 / Accepted: 7 February 2011 / Published online: 25 February 2011
